1[1]Richardson P, Mckenna W, Bristow M. Report of the 1995 World HealthOrganization/International Society and Federation of Cardiology Task Forceon the definitional classification of cardiomyopathies. Circulation, 1996,93:841
2[2]Srivastavara D, Thomas T, Lin Q, et al. Regulation of cardiac mesodermaland neural crest development by the bHLH transcription factor, dHAND.Nat Genet, 1997,16:154
3[3]Grumback IM, Heim A, Vonhof S, et al. Coxsackie virus genome in myo-cardium of patients with arrhythmogenic right ventricular dysplasia/cardio-myopathy. Cardiology, 1998,89: 241
4[4]Nicholson DW, Ali A, Thomberry NA. Identfication and inhibitation ofICE/CED-3 protease necessary for mammalian apoptosis. Nature, 1995,376: 37
5[5]Brembilla Perrot B, Jacqemin L, Houplon P, et al. Increased artrial vulner-ability in arrhythmogenic right ventricular disease. Am Heart J, 1998,135:748
6[6]Dauberte C, Vauthier M, Carre F, et al. Influence of Exercise and sportactivity on functional symptoms in ventricular arrhythmias in ARVD. J AmColl Cardiol, 1998,32:752
7[7]Toyofuku M, Takaki H, Sunagawa K, et al. Exercise induced ST elevationin patients with ARVD.J Electrocardiol, 1999,32:1
8[8]Leclercq JF, Coumel P. Late potentials in ARVD orevalence, diagnosticand prognostic values. Eur Heart J, 1993,14: 80
9[9]Daubert JC, Descares C, Foulgoo JL, et al. Critical analysis of cine angio-graphic criteria for diagnosis of ARVD. Am Heart J, 1998,135: 808
10[10]Ellsion KE, Friedman PL, Ganz LI, et al. Entrainment mapping and radio-frequency catheter ablation of ventricular tachycardia in right ventriculardisease.J Am Coll Cardiol, 1998,32:724
2Rampazzo A,Nava A,Erne P,et al.A new locus for arrhythomgenic right ventricular cardiomyopathy(ARVD2) maps to chromosome q23～q24[J].Hum Mol Genet,1995.2151-2154.
3Mckenna WJ,Thiene G,Nava A,et al.Diagnosis of arrhythmogenic right ventriular dysplasia/cardiomyopathy[J].Br Heart J,1994,71:215-218.
